Venezuela’s Ombudsman Urges Access to Medicine in Economic Crisis

Venezuela's state ombudsman urged the government to accelerate the production of basic medicines in an economic crisis that has caused severe shortages.

"The allocation and delivery of currency for acquiring the raw materials and supplies for manufacturing medicines should be speeded up," the ombudsman, Tarek William Saab, told the legislature.

Growing Drug Crisis in Myanmar Lures More Young People into Drug Addiction
Increased production in the poppy fields and methamphetamine factories of Myanmar's remote borderlands is raising fears of a drug crisis that is luring young people into drug addiction.

‘Venezuela’s ombudsman urged to allocate funds for acquiring raw materials and supplies for manufacturing medicines.’

Tweet it Now

Venezuelans are suffering shortages of basic foods and supplies. The fall in oil prices has slashed the government's main source of revenue.

Saab said the government should "import only that which it is not possible to produce in Venezuela."

Opposition lawmakers who control the legislature were preparing on Tuesday night to pass what they called a law "to tackle the humanitarian health crisis."

Pharmaceutical Companies Delay Drug Access, Not Processing Time
The pharmaceutical company submissions to Health Canada is delaying the access to new prescription drugs rather than delay by a longer approval-processing time, says a study.

Allies of socialist President Nicolas Maduro have vowed to resist, however, branding it a ploy to discredit the government.

The opposition vowed to find legal means to drive Maduro from office after it took control of the legislature in January.

HIV Drug Access Increase Under Licensing Deal
US pharmaceutical giant Gilead Sciences and an NGO called the Medicines Patent Pool announced a deal on Tuesday aimed at boosting access to HIV drugs in poorer countries through generic manufacturing.

Maduro has so far used the courts to resist them and has passed emergency economic measures of his own.

On April 4, he signed an agreement to import medicines from his ally Cuba.

More Money Spent on Research, Still Fewer New Drugs Approved: NIH Study
Among the multiple reasons suspected for the stall in medical progress could be too much focus on getting published in journals and excessive red tape and regulation.

Source-AFP